Identification of mutations and polymorphisms in the factor XI genes of an African American family by dideoxyfingerprinting

Blood

Volumn 92, Issue 9, 1998, Pages 3309-3317

  Martincic, Danko ^b   Zimmerman, Sherri A ^b   Ware, Russell E ^b   Sun, Mao Fu ^b   Whitlock, James A ^b   Gailani, David ^a  

^a VANDERBILT UNIVERSITY   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 11;

AMINO ACID SUBSTITUTION; ARTICLE; BLEEDING; BLOOD CLOTTING FACTOR 11 DEFICIENCY; CASE REPORT; CONTROLLED STUDY; DNA FINGERPRINTING; GENE MUTATION; GENETIC POLYMORPHISM; HUMAN; JEW; MALE; NEGRO; PRIORITY JOURNAL; SCHOOL CHILD;

EID: 0032211183     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v92.9.3309.421k36_3309_3317     Document Type: Article

References (39)

1. Davie EW, Fujikawa K, Kisiel W: The coagulation cascade: Initiation, maintenance and regulation. Biochemistry 30:10363, 1991
2. Asakai R, Chung DW, Davie EW, Seligsohn U: Factor XI deficiency in Ashkenazi Jews in Israel. N Engl J Med 325:153, 1991
3. Seligsohn U, Weiss E, Kulka T, Eichel R, Zwang E, Peretz H: The frequency of the type II and type III mutations causing factor XI deficiency in the general Jewish population. Thromb Haemost 69:1297, 1993 (abstr)
4. Kitchens CS: Factor XI: A review of its biochemistry and deficiency. Semin Thromb Hemost 17:55, 1991
5. Seligsohn U: Factor XI deficiency. Thromb Haemost 70:68, 1993
6. Gailani D: Advances and dilemmas in factor XI. Curr Opin Hematol 1:347, 1994
7. Leiba H, Ramot B, Many R: Heredity and coagulation studies in ten families with factor XI (plasma thromboplastin antecedent) deficiency. Br J Haematol 11:654, 1965
8. Ragni MV, Sinha D, Seaman F, Lewis JH, Spero JA, Walsh PN: Comparison of bleeding tendency, factor XI coagulant activity, and factor XI antigen in 25 factor XI-deficient kindreds. Blood 65:719, 1985
9. Bolton-Maggs PHB, Wan-Yin BY, McCraw AH, Slack J, Kernoff PBA: Inheritance and bleeding in factor XI deficiency. Br J Haematol 69:521, 1988
10. Rappaport SI, Proctor RR, Patch MJ, Yettra M: The mode of inheritance of PTA deficiency: Evidence for the existence of major PTA deficiency and minor PTA deficiency. Blood 18:149, 1961
11. Sidi A, Seligsohn U, Jonas P, Many M: Factor XI deficiency: Detection and management during urologic surgery. J Urol 119:528, 1978
12. Campbell EW, Mednicoff IB, Dameshek MD: Plasma thromboplastin antecedent (PTA) deficiency. Arch Int Med 100:232, 1957
13. Cavins JA, Wall RL: Clinical and laboratory studies of plasma thromboplastin antecedent deficiency (PTA). Am J Med 29:444, 1960
14. Litz CE, Swaim WR, Dalmasso AP: Factor XI deficiency: Genetic and clinical studies of a single kindred. Am J Hematol 28:8, 1988
15. Bouma BN, Griffin JH: Human blood coagulation factor XI, purification, properties, and mechanism of activation by activated factor XII. J Biol Chem 252:6432, 1977
16. Ginsburg D, Sadler JE: von Willebrand disease: A database of point mutations, insertions, and deletions. Thromb Haemost 69:177, 1993
17. Saito H, Ratnoff OD, Bouma BN, Seligsohn U: Failure to detect variant (CRM+) plasma thromboplastin antecedent (factor XI) molecules in hereditary plasma thromboplastin antecedent deficiency: A study of 125 patients of several ethnic backgrounds. J Lab Clin Med 106:718, 1985
18. Asaki R, Chung DW, Ratnoff OD, Davie EW: Factor XI (plasma thromboplastin antecedent) deficiency in Ashkenazi Jews is a bleeding disorder that can result from three types of point mutations. Proc Natl Acad Sci USA 86:7667, 1989
19. Meijers JCM, Davie EW, Chung DW: Expression of human blood coagulation factor XI: Characterization of the defect in factor XI type III deficiency. Blood 79:1435, 1992
20. Pugh RE, McVey JH, Tuddenham EGD, Hancock JF: Six point mutations that cause factor XI deficiency. Blood 85:1509, 1995
21. Arkar G, Yoon H, Sommer SS: Dideoxy fingerprinting (ddF): A rapid and efficient screen for the presence of mutations. Genomics 13:441, 1992
22. Martincic D, Whitlock J: Improved detection of p53 point mutations by dideoxyfingerprinting (ddF). Oncogene 13:2039, 1996
23. Gailani D, Sun M, Sun Y: A comparison of murine and human factor XI. Blood 90:1055, 1997
24. Hillier L, Green P: OSP: A computer program for choosing PCR and DNA sequencing primers. PCR Methods and Applications 1:124, 1991
25. Asakai R, Davie EW, Chung DW: Organization of the gene for human factor XI. Biochemistry 26:7221, 1987
26. Sun Y, Gailani D: Identification of a factor IX binding site on the third apple domain of activated factor XI. J Biol Chem 271:29023, 1996
27. Chen C, Okayama H: High-efficiency transformation of mammalian cells by plasmid DNA. Mol Cell Biol 7:2745, 1987
28. Fujikawa K, Chung DW, Hendrickson LE, Davie EW: Amino acid sequence of human factor XI, a blood coagulation factor with four tandem repeats that are highly homologous with plasma prekallikrein. Biochemistry 25:2417, 1986
29. Rosenthal RL, Dreskin OH, Rosenthal N: New hemophilia-like disease caused by deficiency of a third plasma thromboplastin factor. Proc Soc Exp Biol Med 82:171, 1953
30. Imanaka Y, Lala K, Nishimura T, Bolton-Maggs PHB, Tuddenham EGD, McVey JH: Identification of two novel mutations in non-Jewish factor XI deficiency. Br J Haematol 90:916, 1995
31. Peretz H, Zivelin A, Usher S, Seligsohn U: A 14-base pair-deletion (codon 554 del AAGgtaacagagtg) at the exon 14/intron N junction of the coagulation factor XI gene disrupts splicing and causes severe factor XI deficiency. Hum Mutat 8:77, 1996
32. Ventura C, Santos AIM, Tavares A, de Deus G, Gago T, David D: Molecular pathology of factor XI deficiency in the Portuguese population. Thromb Haemost 87:PS859, 1997 (abstr)
33. Wistinghausen B, Reischer A, Nardi M, Karpatkin M: Severe factor XI deficiency in an Arab family associated with a novel mutation in exon 11. Thromb Haemost 78:PS857, 1997 (abstr)
34. Hayashi T, Satoh S, Suzuki S, Yahagi A, Yoshino M, Sasaki H: Cross-reacting material positive (CRM+) factor XI deficiency, XI Yamagata, with a GT to AT transition at donor splicing site in intron J of the factor XI gene. Thromb Haemost 78:PS1883, 1997 (abstr)
35. Baglia FA, Jameson BA, Walsh PN: Identification and characterization of a binding site for platelets in the apple 3 domain of coagulation factor XI. J Biol Chem 270:6734, 1995
36. Ho DH, Baglia FA, Walsh PN: Identification of contiguous and distinct binding sites for platelets and heparin in the apple 3 domain of coagulation factor XI. Blood 88:282a, 1996 (abstr)
37. Santoro SA, Eby CS: Laboratory evaluation of hemostatic disorders, in Hoffman R, Benz EJ, Shattil, SJ, Furie B, Cohen HJ, Silberstein LE (eds): Hematology: Basic Principles and Practice. New York, NY, Churchill Livingstone, 1995, pp 1622-1632
38. Gailani D, Broze GJ: Factor XI activation in a revised model of blood coagulation. Science 253:909, 1991
39. von dem Borne PA, Meijers JCM, Bouma, BN: Feedback activation of factor XI by thrombin in plasma results in additional formation of thrombin that protects fibrin clots from fibrinolysis. Blood 86:3035, 1995